Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
08/10/2006 | WO2006082071A1 Method for producing a drug extract that contains hydroxystilbene |
08/10/2006 | WO2006066067A3 Formulations of bisphosphonate drugs with improved bioavailability |
08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
08/10/2006 | WO2006050544A3 Tolperison for treating dogs having degenerative spinal symptoms |
08/10/2006 | WO2005103716A3 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
08/10/2006 | US20060179494 Non-human animal exhibiting bone metastasis of tumor cells |
08/10/2006 | US20060178503 Antibody to an integrin heterodimer and/or a subunit thereof |
08/10/2006 | US20060178420 Indole derivatives as anti-inflammatory agents |
08/10/2006 | US20060178413 Diphenylurea derivatives and their use as chloride channel blockers |
08/10/2006 | US20060178409 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
08/10/2006 | US20060178366 Compounds for the treatment of inflammatory disorders |
08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
08/10/2006 | US20060177443 Integrin antagonists |
08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
08/10/2006 | DE102005005446A1 Bruchfeste Darreichungsformen mit retardierter Freisetzung Unbreakable dosage forms with delayed release |
08/10/2006 | DE102005005274A1 Use of a hydroxystilbene-containing active substance combination containing resveratrol and piceatannol precursors, to prevent and/or treat diseases caused by increased serum interleukin-6 level e.g. depression |
08/10/2006 | CA2596993A1 Optically active tetrahydronaphthalene derivative |
08/10/2006 | CA2596186A1 Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis |
08/10/2006 | CA2596178A1 Method for producing a drug extract that contains hydroxystilbene |
08/10/2006 | CA2595860A1 Anti-inflammatory supplement compositions and regimens to reduce cardiovascular disease risks |
08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
08/09/2006 | EP1688481A1 Bifidobacterium in the treatment of inflammatory disease |
08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
08/09/2006 | EP1688416A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
08/09/2006 | EP1688149A1 Paste formulations comprising silica |
08/09/2006 | EP1687311A1 Novel compounds |
08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
08/09/2006 | EP1687265A2 Vitamin d receptor modulators |
08/09/2006 | EP1687258A2 Vitamin d receptor modulators |
08/09/2006 | EP1687065A2 Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor |
08/09/2006 | EP1687010A1 Autologous treatment of degenerated disc with cells |
08/09/2006 | EP1686995A1 Use of cathepsin k inhibitors for treating of severe bone loss diseases |
08/09/2006 | EP1594520B1 Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
08/09/2006 | EP1453949B1 Production of cell suspensions |
08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
08/09/2006 | EP1441737B1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
08/09/2006 | EP1397361B1 Carboline derivatives as pdev inhibitors |
08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
08/09/2006 | EP1181026B1 Improved method for treating mammals with modified mammalian blood |
08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
08/09/2006 | EP1140828B1 3-azabicyclo¬3.1.0|hexane derivatives as opiate receptors ligands |
08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
08/09/2006 | EP1032393B1 Quinoline-containing alpha-ketoamide cysteine and serine protease inhibitors |
08/09/2006 | EP1012177B1 Estrogen receptor |
08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
08/09/2006 | CN1816370A 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
08/09/2006 | CN1816340A Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
08/09/2006 | CN1814303A Microcapsule for promoting bone regeneration and its use |
08/09/2006 | CN1814282A Biological collagen oral liquor and preparing method |
08/09/2006 | CN1814281A Redfish calcitonin inhalation powder-atomizing agent and preparing method |
08/09/2006 | CN1814260A Chinese medicine for treating blood stagnation disease |
08/09/2006 | CN1814247A Chinese medicine bone-setting ointment and preparing method |
08/09/2006 | CN1814245A Chinese medicine remedy for treating cervical vertebra disease |
08/09/2006 | CN1814238A External-use medicinal liquor for treating bone-fracture |
08/09/2006 | CN1814230A Collateral-flow-activating pain-relieving medicine of Herba Vicicae Amoenae |
08/09/2006 | CN1814220A Medicine for treating gout and preparing method |
08/09/2006 | CN1814217A Chinese medicine composition for treating rheumatoid arthritis and use thereof |
08/09/2006 | CN1814215A Medicine for treating gout and gout arthritis |
08/09/2006 | CN1814213A Wind-repellent pain-relieving medicine of |
08/09/2006 | CN1814210A Collateral-flow-activating pain-relieving medicine of Radix Ardisiae Punctate |
08/09/2006 | CN1814207A External-use plaster for treating hyperosteogeny and preparing method |
08/09/2006 | CN1814203A Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls |
08/09/2006 | CN1814202A Damp-repellent pain-relieving medicinal liquor of Rhizoma et Radix caulophy lei |
08/09/2006 | CN1814201A Chinese-medicine cataplasma for treating cervical vertebra disease and preparing method |
08/09/2006 | CN1814180A Collateral-flow-activating pain-relieving medicine of Herba Paederiae |
08/09/2006 | CN1814160A Wind-repellent collateral-flow-activating pain-relieving method of Herba Androsacis Umbellatae |
08/09/2006 | CN1814136A Damp-repellent pain-relieving medicine liquor of Radix Linderae Glaueae |
08/09/2006 | CN1814134A Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls |
08/09/2006 | CN1814122A Medicine for treating osteoporosis and preparing method |
08/09/2006 | CN1814121A Medicine for treating protrusion of intervetebral disc and cervical vertebra disease |
08/09/2006 | CN1814119A Yougui capsule |
08/09/2006 | CN1814118A External-dressing Chinese medicine for treating hyperosteogency, necrosis and cervical vertebra disease |
08/09/2006 | CN1814117A Damp-repellent pain-relieving medicine liquor of caulis seu Radix Parabarii Micranthi |
08/09/2006 | CN1814107A Chinese medicine composition for treating anemogenous-ache disease |
08/09/2006 | CN1814106A Medicine for treating bone injures and preparing method |
08/09/2006 | CN1814105A Medicine for treating hyperosteogeny |
08/09/2006 | CN1814104A Wind-repellent collateral-flow-activating pain-relieving medicine of Radix seu Folium Lobeliae Seguinit |
08/09/2006 | CN1814096A Bone-activating ointment |
08/09/2006 | CN1814088A Wind-repellent collateral-activating pain-relieving medicine of Radix Rhodiolae |
08/09/2006 | CN1814086A Wind-repellent collateral-flow-activating pain-relieving medicine of Radix Scopoliae Sinensis |
08/09/2006 | CN1814080A External-use medicine for treating protrusion of intervertebral disc and hyperosteoguey |
08/09/2006 | CN1814069A Collateral-flow-activating pain-relieving medicine of Herba Antenori Filliformis root |
08/09/2006 | CN1814068A Collateral-flow-activating pain-relieving medicine of Herba sarcandrae |
08/09/2006 | CN1814067A Collateral-flow-activating pain-relieving medicine of caulis parthenocissi laetevirentis |
08/09/2006 | CN1814066A Collateral-flow-activating pain-relieving medicine of caulis et Folium Trachelospermi |
08/09/2006 | CN1814063A Collateral-flow-activating external-use medicine of lysmachiae Grammicae for treating injuries by falls |
08/09/2006 | CN1814056A Wind-repellent collateral-flow-activating pain-rellieving medicine of Radix seu caulis sen Folium seu Fructus callicarpae Giraldii |
08/09/2006 | CN1814045A Bone-setting black plaster |
08/09/2006 | CN1814041A Medicine composition for treating hyperosteogeny |
08/09/2006 | CN1814027A Micropill preparation for treating cervical vertebra and lumbar vertebra disease, and preparing method |